India, Oct. 23 -- In a groundbreaking study, researchers found that a significant portion of anticancer drugs in four African countries, including Kenya and Ethiopia, are substandard or falsified.

This poses a severe risk to patients, as incorrect dosages can lead to ineffective treatment or harmful side effects.

The study calls for enhanced regulatory measures to safeguard the quality of cancer medications.

The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For example, 10 years ago in Ethiopia and Kenya, cancer care was available to only a few thousand patients per year in a few hospitals. Today, over 75,000 people receive cancer treatment each year in each of thes...